BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30304269)

  • 1. Clinical impact and cost analysis of the use of either the Xpert MTB Rif test or sputum smear microscopy in the diagnosis of pulmonary tuberculosis in Rio de Janeiro, Brazil.
    Castro AZ; Moreira AR; Oliveira J; Costa PA; Graça CLALD; Pérez MA; Kritski A; Vater MC
    Rev Soc Bras Med Trop; 2018; 51(5):631-637. PubMed ID: 30304269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
    Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.
    da Silva Antunes R; Pinto M; Trajman A
    Int J Tuberc Lung Dis; 2014 May; 18(5):547-51. PubMed ID: 24903791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
    Pereira GR; Barbosa MS; Dias NJD; Almeida CPB; Silva DR
    PLoS One; 2018; 13(3):e0193988. PubMed ID: 29518135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting.
    Barnard DA; Irusen EM; Bruwer JW; Plekker D; Whitelaw AC; Deetlefs JD; Koegelenberg CF
    BMC Pulm Med; 2015 Sep; 15():103. PubMed ID: 26377395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
    Tadesse M; Aragaw D; Rigouts L; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
    Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
    BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Pinto M; Steffen RE; Cobelens F; van den Hof S; Entringer A; Trajman A
    Int J Tuberc Lung Dis; 2016 May; 20(5):611-8. PubMed ID: 27084814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation.
    Reither K; Manyama C; Clowes P; Rachow A; Mapamba D; Steiner A; Ross A; Mfinanga E; Sasamalo M; Nsubuga M; Aloi F; Cirillo D; Jugheli L; Lwilla F
    J Infect; 2015 Apr; 70(4):392-9. PubMed ID: 25312863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    Kaso AW; Hailu A
    PLoS One; 2021; 16(10):e0259056. PubMed ID: 34695153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the Xpert
    Horo K; N'Guessan R; Koffi MO; Kouamé-N'Takpé N; Koné A; Samaké K; Koffi L; Ahui BJM; Brou-Gode CV; N'Gom A; Kouassi BA; Koffi N; Aka-Danguy E
    Rev Mal Respir; 2017 Sep; 34(7):749-757. PubMed ID: 28189438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.
    Abdurrahman ST; Mbanaso O; Lawson L; Oladimeji O; Blakiston M; Obasanya J; Dacombe R; Adams ER; Emenyonu N; Sahu S; Creswell J; Cuevas LE
    J Clin Microbiol; 2015 Aug; 53(8):2502-8. PubMed ID: 26019204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of the Xpert MTB/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area.
    You JH; Lui G; Kam KM; Lee NL
    J Infect; 2015 Apr; 70(4):409-14. PubMed ID: 25573001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the diagnostic accuracy of the Xpert MTB/RIF assay on bronchoalveolar lavage fluid: A retrospective study.
    Lu Y; Zhu Y; Shen N; Tian L; Sun Z
    Int J Infect Dis; 2018 Jun; 71():14-19. PubMed ID: 29428408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
    Khalil KF; Butt T
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.